Empagliflozin 12.5 mg + Metformin 500 mg IR is a combination oral medication used for the management of type 2 diabetes mellitus. Empagliflozin is a selective SGLT2 inhibitor that reduces blood glucose by promoting the excretion of glucose through urine. Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity. Together, this combination helps in better glycemic control, weight management, and reduces the risk of cardiovascular complications associated with type 2 diabetes. This immediate-release (IR) formulation ensures rapid absorption and effective blood sugar management throughout the day. It is recommended as part of a comprehensive diabetes management plan, including diet and exercise.
